Dominic ffytcheThe Effect of Clazosentan on Clinical Final result after Aneurysmal Subarachnoid Hemorrhage and Endovascular Coiling Study included 571 patients with a ruptured aneurysm treated with an endovascular coil, a device used to repair the ruptured bloodstream vessel. Researchers divided patients into three groups, each given the placebo, 5 mg clazosentan or 15 mg clazosentan. They halted CONSCIOUS-3 prematurely after individuals in CONSCIOUS-2 , which ran concurrently, showed no take advantage of the drug. In CONSCIOUS-3, 27 % of sufferers on placebo died, acquired vasospasm-related blood clots or neurological complications, or acquired rescue therapy to take care of vasospasm, weighed against 24 % in the 5 mg/h and 15 % in the 15 mg/h clazosentan groups.Chlamydia trachomatis genome sheds light on an emerging infection Researchers have got decoded the genome of any risk of strain of Chlamydia that causes the most unfortunate, invasive type of the disease. Their study shows that, despite recent increases in invasive infections, any risk of strain has remained unchanged for 40 years virtually. Chlamydia is the many common treatable bacterial sexually transmitted disease worldwide, with around 90 million cases each year.